Funds and ETFs Piramal Pharma Limited

Equities

PPLPHARMA

INE0DK501011

Pharmaceuticals

Market Closed - NSE India S.E. 07:43:53 2024-05-31 am EDT 5-day change 1st Jan Change
148 INR +1.61% Intraday chart for Piramal Pharma Limited +0.27% +6.63%

ETFs positioned on Piramal Pharma Limited

Name Weight AuM 1st Jan change Investor Rating
0.01% 4 M€ -4.41% -
0.00% 7 M€ +5.36% -
0.00% 112 M€ +4.61% -
0.00% 34 M€ +3.86% -
Piramal Pharma Limited is an India-based pharmaceutical company, which offers a portfolio of differentiated pharma products across a domestic and global distribution network. The Company has approximately 17 global facilities and a global distribution network in over 100 countries. The Company's subsidiaries include Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization; Piramal Critical Care (PCC), a complex hospital generics business, and the India consumer healthcare business selling over-the-counter products. PPS offers end-to-end development and manufacturing solutions through a globally integrated network of facilities across the drug life cycle to generic companies. PCC's complex hospital product portfolio includes inhalation anesthetics, intrathecal therapies for spasticity and pain management, injectable pain, anesthetics, injectable anti-infectives, and other therapies.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
148 INR
Average target price
176 INR
Spread / Average Target
+18.88%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. PPLPHARMA Stock
  4. Funds and ETFs Piramal Pharma Limited